IDEXX Laboratories Inc (IDXX) financials · P/E 39, rev $4.30B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
IDEXX Laboratories Inc (IDXX) P/E 39, rev $4.30B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $4.30B | $3.90B |
| Cost of Revenue | $1.64B | $1.52B |
| Gross Profit | $2.66B | $2.38B |
| Operating Income | $1.36B | $1.13B |
| Net Income | $1.06B | $887.9M |
| EPS (Diluted) | $13.08 | $10.67 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $3.35B | $3.29B |
| Current Assets | $1.41B | $1.40B |
| Cash & Equivalents | $180.1M | $288.3M |
| Inventory | $377.8M | $381.9M |
| PP&E | $747.4M | $713.1M |
| Total Liabilities | $1.75B | $1.70B |
| Current Liabilities | $1.15B | $1.07B |
| Short-term Debt | $75.0M | $167.8M |
| Long-term Debt | $374.8M | $449.8M |
| Total Debt | $449.8M† | $617.6M† |
| Shareholders' Equity | $1.61B | $1.60B |
| Retained Earnings | $6.39B | $5.33B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $1.18B | $929.0M |
| CapEx | $124.7M | $120.9M |
| Investing Cash Flow | -$136.2M | -$207.1M |
| Financing Cash Flow | -$1.16B | -$878.1M |
| Net Change in Cash | -$108.2M | -$165.7M |
| Free Cash Flow | $1.06B | $808.1M |
FAQ
What is IDXX P/E and revenue?
IDEXX Laboratories Inc (IDXX) P/E 39, rev $4.30B.
What is IDXX revenue?
IDEXX Laboratories Inc last cached revenue is $4.30B (FY2025).
Is IDXX profitable?
IDEXX Laboratories Inc last cached net income is $1.06B (FY2025).
What are IDXX total assets?
IDEXX Laboratories Inc last cached total assets are $3.35B (FY2025).
What is IDXX free cash flow?
IDEXX Laboratories Inc last cached free cash flow is $1.06B (FY2025).
Not investment advice. Cached statements, not a live tape.